loader
banner

The U.S. Food and Drug Administration on Wednesday revised the Emergency Use Authorization for Pfizer’s antiviral COVID-19 treatment Paxlovid, allowing pharmacists to prescribe the treatment, with limitations. Paxlovid is authorized for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients 12 years old and older who are at high risk for progression to severe […]

COVID-19 was the leading cause of death for people between the ages of 45 and 54 in 2021, accounting for 16.8% of all deaths in that age group, found a study in JAMA Internal Medicine. It was the third leading cause of death during the height of the pandemic in 2020, surpassed only by cancer […]

Skip to content